EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ezetimibe Normalizes Dietary Cholesterol-Induced Exacerbation of Liver Injury in Alcohol-Fed Mice

Yanchao Xu, Nan Zhang, Piumi B Wickramasinghe, Kavya Veera, Preethi Parupalli, Alex Dao, Junyu Liu, Rithika Anand, Lyndsey E Langley, Sreeja Eadha, Hasan Iqbal, Chen Liu und 2 weitere

Biomolecules · 16.04.2026 · 16 (4) · 590

DOI: 10.3390/biom16040590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 16.04.2026. Verfasst von Yanchao Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Ezetimibe, Cholesterol, Dietary, Anticholesteremic Agents, Ethanol. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health, NIDDK NIH HHS, The University of Texas at Dallas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interactions between alcohol and nutrition play an important role in the development and progression of alcohol-associated liver disease (ALD). Although dietary cholesterol was shown to exacerbate fatty liver and liver injury in alcohol-fed mice, findings regarding the combined effect of dietary cholesterol and heavy alcohol drinking on cholesterol homeostasis remain controversial. Ezetimibe has been widely used as a cholesterol-lowering drug in hypercholesterolemic subjects. It is not fully understood whether ezetimibe blunts the adverse effect of cholesterol on lipid and biliary bile acid metabolism in alcohol-exposed mice. In the current study, wild-type mice were subjected to NIAAA alcohol feeding model. Dietary cholesterol (0.2%, w/v) and ezetimibe (0.001%, w/v) were added to the liquid diets. Cholesterol and triglyceride contents in the liver and circulation were determined. Biliary bile acid composition, as well as hepatic and circulating inflammatory markers were analyzed. We found that ezetimibe protected mice from the synergistic effects of dietary cholesterol and alcohol on hepatic triglyceride accumulation, which was accompanied by enhanced expression of genes involved in hepatic beta oxidation. Dietary cholesterol caused great increases in liver cholesterol content and dramatic reductions in the expression of hepatic cholesterol biosynthetic genes in both control- and alcohol-fed mice. These changes were normalized by ezetimibe treatment. Ezetimibe attenuated dietary cholesterol-induced elevations in total biliary bile acids. Moreover, mice fed a diet containing both cholesterol and alcohol exhibited increased expression of monocyte chemoattractant protein 1 (Mcp1) and tumor necrosis factor alpha (Tnfα) in the distal small intestine. Collectively, our findings indicate that ezetimibe effectively mitigates the adverse effects of dietary cholesterol and alcohol consumption on hepatic lipid accumulation and liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EzetimibeCholesterol, DietaryAnticholesteremic AgentsEthanolLiver Diseases, AlcoholicAnimalsMiceLiverMaleMice, Inbred C57BLTriglyceridesBile Acids and SaltsCholesterol

Stichwörter der Autor:innen

ALDbiliary bile acidcholesterol biosynthesisdietary cholesterolezetimibefatty liver

Substanzen

EzetimibeCholesterol, DietaryTriglyceridesBile Acids and SaltsCholesterolAnticholesteremic AgentsEthanol

Autor:innen und Institutionen

  • Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Biological Sciences, The University of Texas at Dallas, Richardson, TX 75080, USA.
  • Center for Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Bioengineering, The University of Texas at Dallas, Richardson, TX 75080, USA.
  • Office of Research and Innovation, The University of Texas at Dallas, Richardson, TX 75080, USA.

ORCID-Profile: Fang Bian, Lin Jia

Förderung

  • National Institute of Health
  • NIDDK NIH HHS
  • The University of Texas at Dallas
  • National Institute of Alcohol Abuse and Alcoholism
  • The University of Texas at Dallas Office of Research and Innovation

Zitieren

APA

Xu, Y., Zhang, N., Wickramasinghe, P. B., Veera, K., Parupalli, P., Dao, A., Liu, J., Anand, R., Langley, L. E., Eadha, S., Iqbal, H., Liu, C., Bian, F., & Jia, L. (2026). Ezetimibe Normalizes Dietary Cholesterol-Induced Exacerbation of Liver Injury in Alcohol-Fed Mice. Biomolecules, 16(4), 590. https://doi.org/10.3390/biom16040590

Vancouver

Xu Y, Zhang N, Wickramasinghe PB, Veera K, Parupalli P, Dao A, et al. Ezetimibe Normalizes Dietary Cholesterol-Induced Exacerbation of Liver Injury in Alcohol-Fed Mice. Biomolecules. 2026;16(4):590. doi:10.3390/biom16040590

BibTeX
@article{Xu2026,
  author = {Xu, Yanchao and Zhang, Nan and Wickramasinghe, Piumi B and Veera, Kavya and Parupalli, Preethi and Dao, Alex and Liu, Junyu and Anand, Rithika and Langley, Lyndsey E and Eadha, Sreeja and Iqbal, Hasan and Liu, Chen and Bian, Fang and Jia, Lin},
  title = {Ezetimibe Normalizes Dietary Cholesterol-Induced Exacerbation of Liver Injury in Alcohol-Fed Mice},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {590},
  doi = {10.3390/biom16040590}
}
Kostenlos starten →